首页> 外文期刊>ACS applied materials & interfaces >Duplex-Specific Nuclease-Amplified Detection of MicroRNA Using Compact Quantum Dot-DNA Conjugates
【24h】

Duplex-Specific Nuclease-Amplified Detection of MicroRNA Using Compact Quantum Dot-DNA Conjugates

机译:使用Compact Standum DTO-DNA缀合物进行双链特异性核酸酶扩增的MicroRNA

获取原文
获取原文并翻译 | 示例
       

摘要

Advances in nanotechnology have provided new opportunities for the design of next-generation nucleic acid biosensors and diagnostics. Indeed, combining advances in functional nanoparticles, DNA nanotechnology, and nuclease-enzyme-based amplification can give rise to new assays with advantageous properties. In this work, we developed a microRNA (miRNA) assay using bright fluorescent quantum dots (QDs), simple DNA probes, and the enzyme duplex-specific nuclease. We employed an isothermal target-recycling mechanism, where a single miRNA target triggers the cleavage of many DNA signal probes. The incorporation of DNA-functionalized QDs enabled a quantitative fluorescent readout, mediated by Forster resonance energy transfer (FRET)-based interaction with the DNA signal probes. Our approach splits the reaction in two, performing the enzyme-mediated amplification and QD-based detection steps separately such that each reaction could be optimized for performance of the active components. Target recycling gave ca. 3 orders of magnitude amplification, yielding highly sensitive detection with a limit of 42 fM (or 1.2 amol) of miR-148, with excellent selectivity versus mismatched sequences and other miRNAs. Furthermore, we used an alternative target (miR-21) and FRET pair for direct and absolute quantification of miR-21 in RNA extracts from human cancer and normal cell lines.
机译:纳米技术的进展为下一代核酸生物传感器和诊断提供了新的机会。实际上,组合功能纳米颗粒,DNA纳米技术和基于核酸酶的扩增的进步可以产生具有有利性质的新测定。在这项工作中,我们使用明亮的荧光量子点(QDS),简单的DNA探针和酶对双链体核酸酶开发了MicroRNA(miRNA)测定。我们使用一种等温靶循环机制,其中单个miRNA靶触发许多DNA信号探针的切割。 DNA官能化QD的掺入使得通过与DNA信号探针的福尔斯特共振能量转移(FRET)介导的定量荧光读出。基于与DNA信号探针的相互作用。我们的方法分离反应,分别进行酶介导的扩增和基于QD的检测步骤,使得每次反应可以针对活性组分的性能进行优化。目标回收给了加利福。 3级扩增阶数,产生高度敏感的检测,限制了miR-148的42 fm(或1.2 amol),具有优异的选择性与错配序列和其他miRNA。此外,我们使用替代靶(miR-21)和FRET对,用于来自人癌和正常细胞系RNA提取物中的miR-21的直接和绝对定量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号